Report Thumbnail
Product Code OM091370945BB0
Published Date 2022/3/11
English PagesGlobal

Wearable Injectors Market 2022-2028MedicalDevice_MedTech Market


Report Thumbnail
Product Code OM091370945BB0◆The Mar 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2022/3/11
English PagesGlobal

Wearable Injectors Market 2022-2028MedicalDevice_MedTech Market



Abstract


Summary

Global Wearable Injectors Market Size, Share & Trends Analysis Report by Type (On Body, And Off Body), by Technology (Electronic Injector, Mechanical Injector, and Others), by Mechanism of Injection (Motor Driven, Spring Driven, Expanding Battery, Rotary Pump, Collapsible Reservoir, And Pressurized Gas), by Application (Oncology, Infectious Disease, Autoimmune Disease, Cardiovascular Disease, Blood Disorder, And Others) by and End-User (Hospital, Lab And Diagnostics Clinics, Homecare Settings, and Others), Forecast Period (2022-2028) The global wearable injectors market is anticipated to grow at a CAGR of 11.8% during the forecast period. The key factors contributing to the growth of the market are increasing needle stick injuries (NSIs), as this causes occupational danger. For instance, according to World Health Organization (WHO), there were more than two million occupational exposures to sharp injuries that occur among 35 million healthcare workers (HCWs) annually till 2018. This attributed to it danger of developing infectious diseases such as HIV, hepatitis B, and hepatitis C are increased by NSIs that lead to higher adoption of wearable injectors. The global wearable injectors market is segmented based on the type, technology, and mechanism of injection, application, and end-user. On the basis of type, the market is segmented into free apps and paid apps. Based on the platform type, the market is segmented into iOS, Android, and others. Based on the mechanism of injection, the market is subdivided into the motor-driven, spring-driven, expanding battery, rotary pump, collapsible reservoir, and pressurized gas. Based on the application, the market is subdivided into oncology, infectious disease, autoimmune disease, cardiovascular disease, a blood disorder, and others. Based on the end-user, the market is subdivided into hospitals, labs, diagnostics clinics, homecare settings, and others. Among the mechanism of injection segment, spring driven segment is estimated to witness the fastest growth in the market attributed to increasing demand for adhesive patches, as these devices and systems are user-friendly that enable patients to accurately deliver the required drug subcutaneously and owing to the spring driven wearable injectors are growing further in the market. The geographically wearable injectors market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America region is anticipated to hold a prominent share in the market attributed to advanced healthcare infrastructure, high rate of advanced technology adoption, and increasing prevalence of several chronic conditions and lifestyle-related diseases are such factors driving the market growth of the region. For instance, in September 2020, as per the report by the US. Department of Health & Human Services, in the US, 129 million) of civilian, no institutionalized adults had been diagnosed with at least 1 of 10 selected chronic conditions. Among all these prevalence was higher among women (28.4%) than men (25.9%) and increased with advancing age. Moreover, the presence of a large number of market players such as Becton, Dickinson and Co., Johnson & Johnson Services, Inc., and Unilife Corporation are among other are such factors that drive regional market growth further. The major companies serving the global Wearable Injectors market include Becton, Dickinson and Co., Bühler Motor GmbH, E3D Elcam Drug Delivery Devices, Medtronic, Swiss Medical Technology Co., United Therapeutics Corp., Ypsomed AG, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, geographical expansions, partnerships, product launches, and collaborations, to stay competitive in the market. For instance, in February 2021, Phillips-Medisize and Subcuject collaborated to develop and launch a ground-breaking wearable bolus injector to the market. The new system is designed to be a low-cost, patient-friendly, prefilled wearable injector for single-use and the companies are also partnered to meet the growing demand for larger-volume drug delivery. This new Wearable Osmotic Bolus Injector is available for drug-specific wearable injector solution development. Research Methodology The market study of the global Wearable Injectors market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports. Secondary Sources Include • Financial reports of companies involved in the market. • Whitepapers, research papers, and news blogs. • Company websites and their product catalog. The report provides an in-depth analysis of the market size, and the intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models. Market Segmentation 1. Global Wearable Injectors Market Research and Analysis by Type 2. Global Wearable Injectors Market Research and Analysis by Technology 3. Global Wearable Injectors Market Research and Analysis by Mechanism of Injection 4. Global Wearable Injectors Market Research and Analysis by Application 5. Global Wearable Injectors Market Research and Analysis by End-User The Report Covers • Comprehensive research methodology of the global wearable injectors market. • This report also includes a detailed and extensive market overview with key analyst insights. • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations. • Analysis of regional regulations and other government policies impacting the global wearable injectors market. • Insights about market determinants that are stimulating the global wearable injectors market. • Detailed and extensive market segments with the regional distribution of forecasted revenues. • Extensive profiles and recent developments of market players.

Table of Contents

  • 1 Report Summary

    • 1.1 Research Methods and Tools
    • 1.2 Market Breakdown
      • 1.2.1 By Segments
      • 1.2.2 ByRegion
  • 2 Market Overview and Insights

    • 2.1 Scope of the Report
    • 2.2 Analyst Insight & Current Market Trends
      • 2.2.1 Key Findings
      • 2.2.2 Recommendations
      • 2.2.3 Conclusion
  • 3 Competitive Landscape

    • 3.1 Key Company Analysis
    • 3.2 Amgen Inc
      • 3.2.1 Overview
      • 3.2.2 Financial Analysis
      • 3.2.3 SWOT Analysis
      • 3.2.4 Recent Developments
    • 3.3 Becton, Dickinson and Co
      • 3.3.1 Overview
      • 3.3.2 Financial Analysis
      • 3.3.3 SWOT Analysis
      • 3.3.4 Recent Developments
    • 3.4 Bühler Motor GmbH
      • 3.4.1 Overview
      • 3.4.2 Financial Analysis
      • 3.4.3 SWOT Analysis
      • 3.4.4 Recent Developments
    • 3.5 Medtronic
      • 3.5.1 Overview
      • 3.5.2 Financial Analysis
      • 3.5.3 SWOT Analysis
      • 3.5.4 Recent Developments
    • 3.6 Ypsomed AG
      • 3.6.1 Overview
      • 3.6.2 Financial Analysis
      • 3.6.3 SWOT Analysis
      • 3.6.4 Recent Developments
    • 3.7 Key Strategy Analysis
  • 4 Market Segmentation

    • 4.1 Global Wearable Injectors Market By Type
      • 4.1.1 On Body
      • 4.1.2 Off Body
    • 4.2 Global Wearable Injectors Market By Technology
      • 4.2.1 Electronic Injector
      • 4.2.2 Mechanical Injector
      • 4.2.3 Others
    • 4.3 Global Wearable Injectors Market By Mechanism Of Injection
      • 4.3.1 Motor Driven
      • 4.3.2 Spring Driven
      • 4.3.3 Expanding Battery
      • 4.3.4 Rotary Pump
      • 4.3.5 Collapsible Reservoir
      • 4.3.6 Pressurized Gas
    • 4.4 Global Wearable Injectors Market by Application
      • 4.4.1 Oncology
      • 4.4.2 Infectious Disease
      • 4.4.3 Autoimmune Disease
      • 4.4.4 Cardiovascular Disease
      • 4.4.5 Blood Disorder
      • 4.4.6 Others (Immunodeficiency)
    • 4.5 Global Wearable Injectors Market by End-User
      • 4.5.1 Hospital
      • 4.5.2 Lab And Diagnostics Clinics
      • 4.5.3 Homecare Settings
      • 4.5.4 Others (Ambulatory surgery centers)
  • 5 Regional Analysis

    • 5.1 North America
      • 5.1.1 US
      • 5.1.2 Canada
    • 5.2 Europe
      • 5.2.1 UK
      • 5.2.2 Germany
      • 5.2.3 Italy
      • 5.2.4 Spain
      • 5.2.5 France
      • 5.2.6 Rest of Europe
    • 5.3 Asia-Pacific
      • 5.3.1 China
      • 5.3.2 India
      • 5.3.3 Japan
      • 5.3.4 South Korea
      • 5.3.5 Rest of Asia-Pacific
    • 5.4 Rest of the World
  • 6 Company Profiles

    • 6.1 ATS Automation Tooling Systems Inc
    • 6.2 West Pharmaceutical Services, Inc
    • 6.3 E3D Elcam Drug Delivery Devices
    • 6.4 Eitan Medical Ltd
    • 6.5 Enable Injections, Inc
    • 6.6 EOFlow
    • 6.7 e Sonceboz SA
    • 6.8 Insulet Corp
    • 6.9 Neuma LLC
    • 6.10 Noble International, LLC (“Noble”)
    • 6.11 Recipharm AB
    • 6.12 Stevanato Group S.p.a
    • 6.13 Subcuject ApS
    • 6.14 Swiss Medical Technology Co
    • 6.15 United Therapeutics Corp
USD 5,125 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.